新入荷 再入荷

Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry

flash sale icon タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料(
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
中古 3500円 (税込)
数量

Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry

Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine  Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome  Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of  Medicinal ChemistryDesign, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry,Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine  Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome  Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of  Medicinal ChemistryDesign, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation | Journal of Medicinal Chemistry,Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for  cancer immunotherapy | Journal of Hematology & Oncology | Full TextIndoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text,Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for  cancer immunotherapy | Journal of Hematology & Oncology | Full TextIndoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text,Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for  cancer immunotherapy | Journal of Hematology & Oncology | Full TextIndoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy | Journal of Hematology & Oncology | Full Text,

 

レディースの製品

商品情報の訂正

このページに記載された商品情報に記載漏れや誤りなどお気づきの点がある場合は、下記訂正依頼フォームよりお願い致します。

訂正依頼フォーム

商品レビュー

レビューの投稿にはサインインが必要です